[1]
Fayez , H. et al. 2025. Balancing benefit and burden: treatment intensification in paediatric KMT2A rearrangements acute myeloid leukaemia: KMT2A Rearrangements in Pediatric Intermediate-Risk Acute Myeloid Leukemia. Acta Oncologica. 64, (Sep. 2025), 1227–1236. DOI:https://doi.org/10.2340/1651-226X.2025.43878.